Does Sacral Neuromodulation Relieve Chronic Pelvic Cancer Pain, Compared With Medical Treatment?

Assiut University0 sites44 target enrollmentSeptember 10, 2020

ConditionsChronic Pain

Overview

Phase: N/A
Intervention: Not specified
Conditions: Chronic Pain
Sponsor: Assiut University
Enrollment: 44
Primary Endpoint: The change of intensity of pain
Last Updated: 5 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

in this trial, we will test the analgesic efficacy of sacral neuromodulation for patients with pelvic cancer, complaining of chronic pelvic pain in comparison to medical treatment.

Registry

clinicaltrials.gov

Start Date

September 10, 2020

End Date

December 10, 2021

Last Updated

5 years ago

Study Type

Interventional

Study Design

Parallel

Sex

All

Investigators

Sponsor

Assiut University

Responsible Party

Principal Investigator

Diab Fuad Hetta

anesthesia dep. south egypt cancer institute, El methaque st., assuit city, Egypt

Assiut University

Eligibility Criteria

Inclusion Criteria

•Age, 18-70
•Pain localized to the pelvic and perineal region
•The pain is due to pelvic cancer or chronic pelvic pain after pelvic surgery for cancer
•The intensity of pain assessed by VAS (visual analogue pain scale) \> 7
•Importantly, the included participants should gain \> 50% reduction of their pain in response to sacral roots block, S2,3 and 4 with bupivacaine 0.5%, 2 ml for each root